| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study
|
Maiwall, Rakhi
|
|
|
17 |
3 |
p. 662-675
|
artikel
|
| 2 |
Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants
|
Chen, Shen
|
|
|
17 |
3 |
p. 595-605
|
artikel
|
| 3 |
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
|
Gurbuz, Berivan
|
|
|
17 |
3 |
p. 698-708
|
artikel
|
| 4 |
Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis
|
Fan, Hong
|
|
|
17 |
3 |
p. 615-625
|
artikel
|
| 5 |
Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver
|
Crawford, Darrell H. G.
|
|
|
17 |
3 |
p. 522-541
|
artikel
|
| 6 |
Comparative efficacy of PD-1 inhibitors plus lenvatinib and regorafenib after lenvatinib failure for advanced hepatocellular carcinoma: a real-world study
|
Guan, Renguo
|
|
|
17 |
3 |
p. 765-769
|
artikel
|
| 7 |
DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway
|
Li, Yanmeng
|
|
|
17 |
3 |
p. 648-661
|
artikel
|
| 8 |
Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence
|
Melton, Phillip E.
|
|
|
17 |
3 |
p. 584-594
|
artikel
|
| 9 |
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
|
Chang, Te-Sheng
|
|
|
17 |
3 |
p. 550-561
|
artikel
|
| 10 |
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma
|
Xin, Yujing
|
|
|
17 |
3 |
p. 753-764
|
artikel
|
| 11 |
Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study
|
Prabhakar, Tushar
|
|
|
17 |
3 |
p. 745-752
|
artikel
|
| 12 |
Evolution of risk prediction models for post-operative mortality in patients with cirrhosis
|
Kalo, Eric
|
|
|
17 |
3 |
p. 542-545
|
artikel
|
| 13 |
Fibro-Scope V1.0.1: an artificial intelligence/neural network system for staging of nonalcoholic steatohepatitis
|
Yamaguchi, Kanji
|
|
|
17 |
3 |
p. 573-583
|
artikel
|
| 14 |
Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
|
George, Jacob
|
|
|
17 |
3 |
p. 546-549
|
artikel
|
| 15 |
Genetic landscape and immune mechanism of monocytes associated with the progression of acute-on-chronic liver failure
|
Yao, Jia
|
|
|
17 |
3 |
p. 676-688
|
artikel
|
| 16 |
Hyperdynamic circulation in cirrhosis: a novel gutsy central neuronal mechanism
|
Shukla, Akash
|
|
|
17 |
3 |
p. 517-518
|
artikel
|
| 17 |
Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
|
Kang, Min Kyu
|
|
|
17 |
3 |
p. 626-635
|
artikel
|
| 18 |
Intracellular labile iron is a key regulator of hepcidin expression and iron metabolism
|
Li, Yanmeng
|
|
|
17 |
3 |
p. 636-647
|
artikel
|
| 19 |
Liver decompensation: the yard stick that measures indications and adverse effects of human albumin infusion
|
Tiwari, Avinash
|
|
|
17 |
3 |
p. 770-772
|
artikel
|
| 20 |
MAFLD and chronic kidney disease: two sides of the same coin?
|
Pan, Ziyan
|
|
|
17 |
3 |
p. 519-521
|
artikel
|
| 21 |
Oxidative stress triggers hyperdynamic circulation via central neural activation in portal hypertensive rats
|
Liu, Hongqun
|
|
|
17 |
3 |
p. 689-697
|
artikel
|
| 22 |
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
|
Morishita, Asahiro
|
|
|
17 |
3 |
p. 606-614
|
artikel
|
| 23 |
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
|
Yang, Xu
|
|
|
17 |
3 |
p. 709-719
|
artikel
|
| 24 |
Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma
|
Ito, Ryo
|
|
|
17 |
3 |
p. 735-744
|
artikel
|
| 25 |
The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases
|
Lee, David Uihwan
|
|
|
17 |
3 |
p. 720-734
|
artikel
|
| 26 |
The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCV-comparable to SMR (standardized mortality ratio) of Japan general population
|
Obi, Shuntaro
|
|
|
17 |
3 |
p. 562-572
|
artikel
|
Tijdschrift beschrijving